Breadcrumbs

DIR 183

Clinical trial with genetically modified E.coli to reduce antibiotic resistance

Licence details

Licence number:
DIR 183
Licence status:
Current
Category:
Medical
Release:
Limited and controlled
Organisation:

The Westmead Institute for Medical Research

Parent organism:

Escherichia coli

Modified trait:

Human therapeutic – reduce antibiotic resistance in gut bacteria

Licence issue date:
Description:

The Westmead Institute for Medical Research is conducting a clinical trial with genetically modified (GM) E.coli to reduce antibiotic resistance.

The trial aims to treat 100 participants over 5 years. To be eligible, participants need to have bacteria carrying a specific type of antibiotic resistance. They will be treated under controlled conditions at Westmead Hospital in Sydney.

The RARMP concluded that the clinical trial poses negligible risks to people or the environment. However, as this is a clinical trial under limited and controlled conditions, licence conditions have been imposed to:

  • restrict when and where the trial can take place
  • limit the size of the trial
  • restrict the spread and persistence of the GM vaccine.
Date application received:
RARMP open for public consultation:
RARMP closed for public consultation:

Documents

Licence decision - notification

Outlines the Regulator’s decision to issue a licence following the assessment of this application.

Licence decision - Q&A

FAQs on the licence application and the Regulator’s decision to issue a licence for this application.

Risk assessment and risk management plan - summary

A summary of the Risk Assessment and Risk Management Plan prepared as part of the assessment of this application. It provides a brief description of the licence application, the risk assessment and risk management plan.

Risk assessment and risk management plan - full version

The final risk assessment and management plan prepared to support the Regulator's decision. It describes the GMO(s) and proposed work with the GMO(s) and provides an assessment of potential risks posed by the GMO(s). It also includes a summary of submissions received during the public consultation process.

Licence conditions

Sets out the licence conditions imposed by the Regulator, including the licence holder’s general and specific obligations and reporting requirements.

Last updated: